Dipraglurant, aslo known as ADX-48621, is a negative allosteric modulator of the mGlu5 receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID).
For research use only. We do not sell to patients.
Iupac Chemical Name 6-Fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]imidazo[1,2-a]pyridine
Synonyms ADX-48621; ADX48621; ADX 48621; Dipraglurant
Molecular Formula C16H12FN3
Molecular Weight 265.2914
CAS Number 872363-17-2
Packaging Price Availability Purity Shipping Time
Bulk Enquiry Enquiry Enquiry
Formulation Off-white solid to white solid
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility Soluble in DMSO
Shipping Condition Shipped under ambient temperature